CA 15-3
Showing 1 - 25 of >10,000
Breast Cancer Trial in Italy (Arm B, tumor markers assessment)
Active, not recruiting
- Breast Cancer
- Arm B, tumor markers assessment
-
Bressanone, Bolzano, Italy
- +6 more
Dec 28, 2022
A Prospective Longitudinal Breast Cancer Study
Completed
- Breast Cancer
- CA 15-3 Assay
-
Boca Raton, Florida
- +2 more
Aug 16, 2021
PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer
Not yet recruiting
- Breast Cancer
- PET/CT
- (no location specified)
Sep 30, 2021
People Who Have Genetic Changes and Features of Autism: Simons
Recruiting
- 16P11.2 Deletion Syndrome
- +184 more
-
New York, New York
- +1 more
Jan 6, 2023
PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib
Completed
- PIK3CA-Related Overgrowth Spectrum (PROS)
-
Boston, Massachusetts
- +6 more
Sep 27, 2021
Bacterial Vaginosis, Candidosis Vaginal, Urinary Tract Infections Trial in Catania (Lacticaseibacillus rhamnosus CA15 (DSM
Recruiting
- Bacterial Vaginosis
- +2 more
- Lacticaseibacillus rhamnosus CA15 (DSM 33960) probiotic strain
- placebo
-
Catania, ItalyUniversity of Catania
Apr 6, 2023
PIK3CA-related Overgrowth Spectrum (PROS) Trial in Worldwide (Alpelisib, Placebo)
Recruiting
- PIK3CA-related Overgrowth Spectrum (PROS)
- Alpelisib
- Placebo
-
Los Angeles, California
- +38 more
Nov 25, 2022
Alzheimer, Alzheimer 1, Alzheimer 2 Trial in United States (Sensory Stimulation System (GS120) - Active, Sensory Stimulation
Recruiting
- Alzheimer Disease
- +34 more
- Sensory Stimulation System (GS120) - Active
- Sensory Stimulation System (GS120) - Sham
-
Washington, District of Columbia
- +24 more
Jan 27, 2023
Healthy Volunteers Trial in Shijiangzhuang (15-valent pneumococcal conjugate vaccine 202210001, 15-valent pneumococcal conjugate
Recruiting
- Healthy Volunteers
- 15-valent pneumococcal conjugate vaccine 202210001
- +4 more
-
Shijiangzhuang, Hebei, ChinaHebei Provincial Center for Disease Control and Prevention
Jul 11, 2023
Advanced Hepatocellular Carcinoma Trial in Worldwide (Enzalutamide, Placebo)
Completed
- Advanced Hepatocellular Carcinoma
- Enzalutamide
- Placebo
-
San Francisco, California
- +37 more
Feb 18, 2022
Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)
Completed
- Melanoma
- +3 more
- Binimetinib Oral Tablet
-
Rennes, FranceBiotrial
Mar 31, 2023
Postsurgical Pain Trial in Pasadena (CA-008 5 mg, Placebo, Bupivacaine Hydrochloride)
Completed
- Postsurgical Pain
- CA-008 5 mg
- +8 more
-
Pasadena, CaliforniaLotus Clinical Research, LLC
Jan 4, 2022
Photoaging, Lentigo Trial (15% Trichloroacetic acid + 3% glycolic acid)
Not yet recruiting
- Photoaging
- Lentigo
- 15% Trichloroacetic acid + 3% glycolic acid
- (no location specified)
Jul 28, 2022
Osteopenia or Osteoporosis Trial in Myrina (Functional olive paste, Calciovitmag (CDCaMg), Phosporovitmag (PDCaMg))
Completed
- Osteopenia or Osteoporosis
- Functional olive paste
- +3 more
-
Myrina, Limnos/Lesvos, GreeceUniversity of the Aegean
Nov 16, 2023
PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)
Completed
- PIK3CA Mutation-Related Tumors
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 9, 2023
Autosomal Recessive Polycystic Kidney (ARPKD) Trial in Worldwide (Tolvaptan Suspension, Tolvaptan Tablets)
Not yet recruiting
- Autosomal Recessive Polycystic Kidney (ARPKD)
- Tolvaptan Suspension
- Tolvaptan Tablets
-
Washington, District of Columbia
- +18 more
Jul 27, 2022
ABL90 FLEX PLUS Clinical Precision Study for 15 Parameters in
Recruiting
- Diagnostic Test
- ABL90 FLEX PLUS analyser running SW3.5 MR2.
-
Copenhagen, Østerbro, DenmarkTejs Jansen
Mar 26, 2023
HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)
Active, not recruiting
- HER2-positive Breast Cancer
- PIK3CA analysis
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023
Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)
Recruiting
- Endometrial Cancer
- Ovarian Cancer
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2022
Patterns Among PIK3CA Mutation in Advanced Breast Cancer
Completed
- Breast Cancer
-
East Hanover, New JerseyNovartis
Aug 1, 2023
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Performance of Colonoscopy, Tolerance of Colonoscopy Trial in Mexico city (Abdominal binder (Revive 3-in-1 Postpartum Recovery
Recruiting
- Performance of Colonoscopy
- Tolerance of Colonoscopy
- Abdominal binder (Revive 3-in-1 Postpartum Recovery Support Belt)
- Loose abdominal binder (Revive 3-in-1 Postpartum Recovery Support Belt)
-
Mexico city, MexicoAntonio Marmolejo
Jan 28, 2023
Breast Cancer Trial (diagnostic test, radiation, other)
Unknown status
- Breast Cancer
- Serum Autotaxin
- +10 more
- (no location specified)
Mar 30, 2020